All Research Studies
Browse all 55 peer-reviewed studies that have shaped our understanding of peptide mechanisms, dosing protocols, and safety considerations.
Retatrutide for Long-Term Weight Maintenance in Adults with Obesity (TRIUMPH-3)
Phase 3 TRIUMPH-3 trial evaluating sustained weight loss and cardiometabolic outcomes with retatrutide over 88 weeks in adults with obesity.
Tirzepatide and MACE Reduction in Type 2 Diabetes with Established CVD (SURPASS-CVOT)
Cardiovascular outcomes trial reporting major adverse cardiovascular event reduction with tirzepatide versus dulaglutide in high-risk T2D patients.
Pharmacokinetics and Tendon Repair Outcomes of BPC-157 in a Randomized Controlled Pilot
First randomized controlled pilot characterizing BPC-157 pharmacokinetics and patient-reported tendon repair outcomes following subcutaneous administration.
CagriSema versus Tirzepatide for Obesity: 68-Week Head-to-Head Trial
Head-to-head Phase 3 comparison of CagriSema and tirzepatide showing differentiated weight loss, tolerability, and body composition outcomes.
Safety of Intravenous Infusion of BPC157 in Humans: A Pilot Study
Pilot study by Lee & Burgess evaluating the safety profile of intravenous BPC-157 administration in human subjects.
Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Phase 2 trial by Jastreboff et al. evaluating the triple-hormone-receptor agonist retatrutide for obesity treatment.
Tirzepatide versus Semaglutide Once Weekly in Type 2 Diabetes (SURPASS-2)
SURPASS-2 trial by Frías et al. comparing tirzepatide to semaglutide in type 2 diabetes management.
Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
SURMOUNT-1 trial by Jastreboff et al. demonstrating tirzepatide's significant weight reduction efficacy.
Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)
Landmark STEP 1 trial by Wilding et al. demonstrating semaglutide's efficacy for weight management in adults with overweight or obesity.
Thymosin Beta 4: A Multi-Functional Regenerative Peptide
Goldstein et al. review thymosin beta-4's multi-functional regenerative properties across tissue types.
All studies loaded.